Amydis Clinical Trials

The Leader in Detecting Ocular Biomarkers for Diseases of the Eye, Heart, and Brain

Alzheimer’s Disease Trial

Amydis is developing an eye test that can label and detect amyloid in the retina. This test could help doctors diagnose and monitor AD, and potentially catch the disease early by a simple, low-cost eye scan.

Cerebral Amyloid Angiopathy Trial

With the help of Amydis’ non-invasive eye test, early diagnosis of CAA may be possible, enabling the opportunity for improved patient care by detecting diseases earlier when they can be most effectively treated.

Who to contact regarding possible participation?

Enrolled participants will receive a stipend.

Dr. David Wirta

Dr. Benjamin Bakall

Associated Retina Consultants
1750 E. Glendale Ave
Phoenix, AZ 85020

Attn: Mallory Mintert  480-999-5458 
Email: mallory.mintert@doctrials.com